Merck Tbk PT logo

Merck Tbk PT (MERK)

Market Open
12 Jun, 08:49
IDX IDX
Rp
3,500. 00
+80
+2.3392%
Rp
1.38T Market Cap
10.17 P/E Ratio
680% Div Yield
90,000 Volume
0 Eps
Rp 3,420
Previous Close
Add Transaction
Day Range
3,390 3,590
Year Range
2,720 4,500
Want to track MERK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MERK trading today higher at Rp3,500, an increase of 2.3392% from yesterday's close, completing a monthly decrease of -11.3924% or -Rp450. Over the past 12 months, MERK stock gained 4.4776%.
The next announced payment will be in In 1 weeks on Jun 24, 2026 for a total of Rp275.
The last earnings report, released on May 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Merck Tbk PT has completed 1 stock splits, with the recent split occurring on Dec 21, 2015.
The company's stock is traded on one exchange.

MERK Chart

People also search for

Jasa Marga (Persero) Tbk PT
Rp 2,660
+2.3077%
Daya Intiguna Yasa Tbk. PT
Rp 860
+1.1765%
Mitra Adiperkasa Tbk.
Rp 1,485
-0.3356%
Industri Jamu dan Farmasi Sido Muncul Tbk.
Rp 380
+3.2609%
Golden Flower Group Plc
Rp 15,100
+7.6649%

Merck Tbk PT (MERK) FAQ

What is the stock price today?

The current price is Rp3,500.00.

On which exchange is it traded?

Merck Tbk PT is listed on IDX.

What is its stock symbol?

The ticker symbol is MERK.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 680%.

What is its market cap?

As of today, the market cap is 1.38T.

Has Merck Tbk PT ever had a stock split?

Merck Tbk PT had 1 splits and the recent split was on Dec 21, 2015.

Merck Tbk PT Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Evie Yulin CEO
IDX Exchange
ID1000136609 ISIN
Indonesia Country
369 Employees
8 Jun 2026 Last Dividend
21 Dec 2015 Last Split
23 Jul 1981 IPO Date

Overview

PT Merck Tbk, established in 1970 and based in East Jakarta, Indonesia, is a prominent pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products within the Indonesian market. Operating through Biopharma, Consumer Health, and Others segments, PT Merck Tbk has a diverse portfolio that targets various health conditions. Initially known as PT Merck Indonesia Tbk until June 2002, the company has seen significant transformations over the years to better align with its market and operational strategies. As a subsidiary of Merck Holding GmbH, it benefits from a strong global network in the pharmaceutical industry, ensuring a steady flow of innovation and high-quality standards. PT Merck Tbk also extends its operations to office/property leasing and management, showcasing a diversified business model.

Products and Services

  • Cardiovascular and Metabolic Products

    These include a range of drugs aimed at treating conditions related to the heart and blood vessels, as well as metabolic disorders. PT Merck Tbk offers innovative solutions to improve patient outcomes in diseases such as hypertension and diabetes.

  • Oncology

    PT Merck Tbk provides a portfolio of drugs for the treatment of various cancers, including colorectal cancer and head and neck cancer. These products are part of an extensive effort to combat the growing rate of cancer through effective treatments.

  • Neurodegenerative Diseases

    This category covers medicines for disorders like multiple sclerosis, addressing the needs of patients suffering from diseases that affect the brain and nerves.

  • Endocrinology and Fertility

    These products cater to hormonal disorders, including growth hormone deficiencies, and issues related to infertility. PT Merck Tbk is involved in both the development and marketing of treatments to help individuals and couples facing these challenges.

  • General Medicines

    The company offers a broad range of general medicines, covering various therapeutic areas. This includes treatments for thyroid disorders such as hyperthyroidism and hypothyroidism, ensuring a comprehensive approach to healthcare.

  • Property Leasing and Management

    Beyond pharmaceuticals, PT Merck Tbk is engaged in office and property leasing and management, providing spaces for businesses and professionals. This diversifies its revenue streams and showcases the company's versatility in the marketplace.

Contact Information

Address: Jl. TB Simatupang No. 8
Phone: 62 21 2856 5600